| Trial ID: | L5143 |
| Source ID: | NCT02292290
|
| Associated Drug: |
Liraglutide
|
| Title: |
Trial for People With Established Type 2 Diabetes During Ramadan
|
| Acronym: |
T4R
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Liraglutide|DRUG: Liraglutide|DRUG: Sulfonylurea or Pioglitazone|DRUG: Maintain dual therapy (Sulf/Pio) as comparator to Liraglutide
|
| Outcome Measures: |
Primary: Composite, A composite endpoint of a reduction in weight, reduction/maintenance of HbA1c and elimination of severe hypoglycaemic (defined as hospital admission) events post intervention., 12 weeks following post Ramadan cinical assessment | Secondary: HbA1c only, Mean change HbA1c level, same as primary, 12 weeks following post Ramadan cinical assessment
|
| Sponsor/Collaborators: |
Sponsor: University of Leicester | Collaborators: University Hospitals, Leicester|University Hospital Birmingham
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
99
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-04
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2020-01-30
|
| Locations: |
University Hospitals of Leicester, Leicester, Leicestershire, United Kingdom|University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT02292290
|
